Home » Mycoplasma pneumonia in children, first cases also in Italy after China, France, Holland and Denmark – breaking latest news

Mycoplasma pneumonia in children, first cases also in Italy after China, France, Holland and Denmark – breaking latest news

by admin
Mycoplasma pneumonia in children, first cases also in Italy after China, France, Holland and Denmark – breaking latest news

by Health Editorial Staff

The Higher Institute of Health reports two cases of Mycoplasma pneumoniae in children hospitalized with respiratory symptoms from the reference laboratory of Perugia. But this is not a new pathogen

Now that attention has increased for this bacterium, which is suspected to be among the causes of an increase in hospitalizations of children for pneumonia in China and in some European countries such as France, Holland and Denmark, cases are also starting to be reported in our country where It is worth repeating that Mycoplasma has always circulated in the community. This was specified by the Higher Institute of Health, in the aftermath of the latest RespiVirNet surveillance report, coordinated by the ISS in collaboration with the Ministry of Health, in which two cases of Mycoplasma pneumoniae were detected (HOW TO BE RECOGNIZED HERE) in hospitalized children with respiratory symptoms from the reference laboratory of Perugia, one relating to the week from 20 to 26 November (coinfection with rhinovirus) and one for the current week, in line with what is expected in this period.

Online questions and answers

The ISS underlines that its timely identification shows how the surveillance network is able to record its presence and, consequently, also a possible increase in the number of cases over time. In recent days there has been a lot of talk in the media about Mycoplasma pneumoniae infections, also in relation to the increase in hospitalizations of children in various countries, explains the ISS which, to clarify, publishes some of the most common questions and answers are online, edited by the Infectious Diseases department.

See also  G20: Minister wants to promote pharmaceutical research

Mycoplasma pneumoniae is a bacterium that colonizes the respiratory tract, causing infections ranging from mild and often self-limiting symptoms (colds, pharyngitis) to more severe forms such as pneumonia. In particular, this microorganism is commonly known as the etiological agent for atypical pneumonia, capable of occurring in pre-school subjects, young adults and in subjects with complications or immunological alterations. It is estimated that it causes between 10 and 20% of all pneumonias globally, experts highlight.

Not a new bacterium

But is it a new pathogen? This pathogen has been well known for years – the ISS points out – and Mycoplasma infection is quite common, especially up to 6 years of age. Epidemics occur periodically. What are the symptoms? The infection generally causes no symptoms – the ISS further illustrates – or mild respiratory symptoms. In some cases, however, it can cause pneumonia, which in more serious situations may require hospitalization. In the patient, Mycoplasma pneumoniae can often be present simultaneously with other pathogens, such as respiratory viruses. This co-infection supported by multiple pathogens can exacerbate symptoms and require hospitalization. But how is it treated? Fortunately – experts reassure – Mycoplasma pneumoniae is sensitive to various antibiotics and therefore the infection can be treated through the application of well-known and verified medical protocols.

Corriere della Sera also on Whatsapp. sufficient click here to subscribe to the channel and always be updated.

December 2, 2023 (modified December 2, 2023 | 6:01 pm)

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy